Medicine and Dentistry
Sodium Glucose Cotransporter 2 Inhibitor
100%
Maturity Onset Diabetes of the Young
57%
Cardiovascular System
42%
Hypertension
42%
Blood Pressure
42%
Antihypertensive Agent
42%
Therapeutic Procedure
42%
Patient with Type 2 Diabetes
28%
Glucose
14%
Drug Therapy
14%
Combination Therapy
14%
Glycemic Control
14%
Vascular Resistance
14%
Cardiovascular Risk
14%
Myocardial Infarction
14%
Diuresis
14%
Sodium Glucose Cotransporter 2
14%
Apoplexy
14%
Arterial Stiffness
14%
Drug
14%
Chemotherapeutic Agent
14%
Blood Pressure Monitoring
14%
Empagliflozin
14%
Patient
14%
Inpatient
14%
Weight Loss
14%
Pharmacology, Toxicology and Pharmaceutical Science
Sodium Glucose Cotransporter 2 Inhibitor
100%
Non Insulin Dependent Diabetes Mellitus
57%
Hypertension
42%
Antihypertensive Agent
42%
Combination Therapy
14%
Glucose
14%
Cardiovascular Risk
14%
Heart Infarction
14%
Drug
14%
Empagliflozin
14%
Sodium Glucose Cotransporter 2
14%
Death
14%